Medical Device Distribution Agreements in New Zealand

If you are appointing a distributor for medical devices in New Zealand, the main legal risk is assuming a standard distribution contract will cover regulatory compliance, product liability and market conduct. It often does not. Businesses commonly sign terms that are silent on who handles import obligations, rely on verbal promises about exclusivity or sales targets, or leave recalls and adverse event reporting too vague to be useful when something goes wrong.

A medical device distribution agreement needs to do more than set price and territory. It should clearly allocate regulatory responsibilities, quality controls, reporting obligations, marketing limits and liability between the supplier and distributor. That matters whether you are an overseas manufacturer entering New Zealand, a local importer appointing resellers, or an established distributor taking on a new device range.

This guide explains what a medical device distribution agreement usually covers in New Zealand, the legal issues to check before you sign, and the mistakes that most often create disputes later.

Overview

A well-drafted medical device distribution agreement reduces confusion about who is responsible for compliance, customer claims and stock problems once products are in market. In New Zealand, that means the contract should work alongside general contract law, fair trading rules, consumer protection laws where applicable, and the practical regulatory framework affecting medical devices.

• define the products, channels, territory and whether the appointment is exclusive, sole or non-exclusive
• allocate responsibility for importation, product information, labelling, tracking, adverse event reporting and recalls
• set pricing, payment terms, minimum orders, sales targets and stock holding obligations
• control marketing claims, training, use of branding and who approves promotional material
• deal with warranties, indemnities, liability clauses, insurance obligations and customer complaints
• cover term, renewal, termination rights, post-termination stock sell-off and return of confidential information

What Medical Device Distribution Agreement Means For New Zealand Businesses

A medical device distribution agreement is the contract that sets the commercial and legal rules for how medical devices will be supplied, promoted and sold through a distributor. For New Zealand businesses, it is the document that should spell out not just the sales arrangement, but also how regulatory and quality risks are shared.

In practice, these agreements are used in a few common founder situations. An overseas manufacturer may appoint a New Zealand distributor to import and sell products locally. A New Zealand importer may appoint sub-distributors or resellers across clinics, hospitals or retail channels. A local distributor may also sign with a manufacturer for a new product line and accept obligations around training, support and complaint handling.

Medical devices create extra pressure because the products are used in health settings and mistakes can have real safety consequences. That means ordinary distribution clauses are not enough on their own. The contract should connect operational tasks, like product storage, batch tracking and complaint escalation, with clear legal responsibility.

What the agreement usually covers

The contract will usually set out the basic commercial deal first. That includes which products are covered, where they can be sold, whether sales are restricted to certain channels, and how orders are placed and paid for.

It should then go further and address the legal and operational points that are easy to miss before you sign. These often include:

• who is the importer of record and who handles border, customs and shipping risk
• what product documentation must be supplied, such as instructions for use, technical information and safety material
• who can make representations to hospitals, clinicians, procurement teams and end users
• what stock rotation, shelf-life, storage and transport standards apply
• what happens if the manufacturer changes specifications, packaging or labelling
• how defects, field safety actions and recalls are managed

Why New Zealand context matters

New Zealand businesses should not assume an overseas template will fit the local market. A contract drafted for the United States, Europe or Australia may refer to regulations, approvals or market structures that do not line up neatly with New Zealand practice.

The legal setting also matters because distributors can create exposure under general business laws, not just sector-specific rules. If a distributor makes exaggerated performance claims, unclear supply promises or misleading statements about certification, both parties may face problems under fair trading rules. If products are supplied to consumers in some channels, consumer guarantees may also affect how returns, defects and remedies work, even if your written terms say something different.

This is where founders often get caught. They focus on margin, exclusivity and targets, but the real dispute later is about who should pay for returned stock, who was allowed to approve advertising, or who bears the cost of a recall after a complaint from a clinic.

Exclusive versus non-exclusive appointments

Exclusivity is one of the first issues parties negotiate, and one of the easiest to leave unclear. If a distributor believes it has exclusive rights for New Zealand, but the supplier thinks it can keep selling directly to key accounts, the relationship can break down quickly.

Your agreement should state clearly whether the appointment is:

• exclusive, meaning only that distributor can sell the products in the defined territory or channel
• sole, meaning the supplier may reserve some direct sales rights while no other distributors are appointed
• non-exclusive, meaning the supplier can appoint others and sell directly

If there is any exclusivity, the contract should also say what the distributor must do to keep it. That might include minimum purchase levels, launch milestones, regulatory support obligations, reporting standards or coverage requirements.

Legal Issues To Check Before You Sign

Before you sign a medical device distribution agreement, make sure the contract allocates legal responsibility with precision. If the key clauses are vague, the party closest to the problem often ends up carrying the cost, even if that was never the original commercial intention.

Product scope and technical changes

The products covered by the agreement should be identified clearly, ideally by model, catalogue number, version or schedule. General wording such as “all future products” can create arguments if the manufacturer introduces modified devices, software updates, accessories or replacement parts.

The contract should also deal with product changes. Check whether the supplier can change specifications, packaging, instructions or manufacturing location without consent, and what notice must be given. For a distributor, this matters because a technical change may affect stock on hand, customer commitments, training materials and marketing approvals.

Regulatory and compliance responsibility

The agreement should say who is responsible for each practical compliance task in New Zealand. A broad statement that both parties will comply with all applicable laws is not enough for a product category with safety and reporting issues.

You should identify responsibility for:

• importing the device into New Zealand and meeting any importer-side obligations
• maintaining product information and technical documentation
• supplying compliant labelling, instructions and warnings
• keeping records for traceability, serial numbers or batch tracking where relevant
• reporting product complaints, adverse events or safety concerns up the chain
• managing recalls, field corrections and customer notifications

If the device is sold into clinical settings, the agreement should also address training and use limitations. A distributor should not be left to create its own training content or performance claims without supplier approval.

Marketing claims and fair trading risk

The contract should strictly control what the distributor can say about the product. Medical device marketing can create legal exposure if claims about performance, approvals, clinical outcomes or compatibility are overstated or not properly supported.

Your agreement should cover who approves promotional material, whether the distributor can translate or adapt supplier content, and what happens if a regulator, hospital or customer challenges a claim. It is also sensible to prohibit informal promises that go beyond approved materials, especially where sales staff are dealing directly with clinicians or procurement teams.

Before you rely on a verbal promise, get it into the contract. If the supplier says the product can be marketed for a particular use, or the distributor says it can secure a certain account base, record the exact position and any assumptions.

Pricing, targets and stock risk

Distribution disputes often start with stock and cash flow, not regulation. The agreement should state the price list process, payment timing, credit terms, currency, freight treatment and when title and risk pass.

If there are minimum purchase obligations or sales targets, they need careful contract drafting. Check:

• how targets are measured, such as units, revenue or account openings
• whether targets are fixed or reviewed periodically
• what market assumptions were used
• what happens if stock shortages or regulatory delays affect sales
• whether missing a target ends exclusivity, triggers a cure period or allows termination

Stock buy-back rights are another major issue. If products have expiry dates, sterile packaging, firmware dependencies or narrow shelf-life windows, the distributor should not be left holding unsaleable inventory after termination or a product update.

Warranties, indemnities and liability

This section decides who pays when things go wrong. A supplier will often want narrow warranty wording and a low liability cap. A distributor will want protection if the product is defective, non-compliant or does not match approved specifications.

The contract should deal separately with:

• product defects and manufacturing faults
• failure to meet specifications or documentation requirements
• breach of law or misleading claims by either party
• third-party intellectual property infringement claims
• personal injury or property damage connected to the device

Liability caps also need scrutiny. A general cap tied to fees paid under the agreement may not make sense if recall costs or hospital claims could far exceed recent purchase volumes. Sometimes certain liabilities, such as fraud, confidentiality breaches, intellectual property infringement or product liability claims, are carved out of the cap.

Insurance requirements should line up with these risks. It is sensible to specify what cover each party must maintain and whether evidence of insurance must be provided on request.

Recall and complaint procedures

If a complaint comes in from a clinic, pharmacy, hospital buyer or patient-facing channel, the agreement should tell staff exactly what happens next. This is not a clause to leave for later.

A workable recall and complaint clause should cover:

• how complaints are recorded and escalated
• timeframes for notifying the other party
• who investigates and who decides whether corrective action is needed
• who communicates with customers and prepares scripts or notices
• who pays the direct costs of retrieving, replacing or destroying stock
• what records must be kept after the event

Term, termination and exit planning

A medical device distribution agreement should not only describe the relationship when things are going well. It should also say how the parties unwind it without damaging customers, stock value or market reputation.

Check the initial term, renewal mechanism, termination for breach, insolvency and convenience rights. Also review what happens to pending orders, service commitments, customer data, confidential information, spare parts, training obligations and unsold stock after termination.

Where hospital or clinic relationships are involved, handover mechanics matter. The supplier may need a right to communicate directly with affected customers, while the distributor may need payment protection for orders generated before the agreement ended.

Common Mistakes With Medical Device Distribution Agreement

The most common mistake is treating the agreement like a generic product distribution contract. Medical devices bring added pressure around product information, traceability, safety responses and sales conduct, so a basic template often leaves the highest-risk issues unclear.

Accepting the supplier's standard terms without adapting them

Many distributors are handed a global template and told it is non-negotiable. In reality, standard terms are usually drafted to protect the supplier's position across many markets. They may not deal properly with New Zealand sales channels, local customer expectations or the actual way the parties will operate.

This becomes a problem where the template says the distributor is responsible for all local compliance, but the supplier keeps control over labels, instructions and technical claims. That split can leave the distributor liable for matters it does not control.

Leaving exclusivity vague

Founders often rely on emails or sales discussions that suggest the distributor will have “the New Zealand market”. If the signed contract does not clearly grant exclusivity, define the territory and set out any reserved accounts or online rights, the supposed protection may not exist.

The same issue comes up with channel conflict. A supplier may appoint a distributor for hospitals but still sell online, through procurement panels or through an affiliated reseller. If channel carve-outs are not written down, arguments start once revenue appears.

Ignoring complaint handling until a problem appears

When a product issue arises, teams need a procedure, not a debate. If the agreement does not define who investigates complaints, who can speak to customers, and who bears the cost of replacement stock, delay can make the commercial damage worse.

This is especially risky where the device is used by healthcare professionals and customer confidence matters. A slow or inconsistent response can damage account relationships even if the technical issue is minor.

Overlooking marketing control

Distributors often want flexibility to tailor sales material for local customers. That is commercially sensible, but it can create risk if the agreement does not require approval of claims, imagery or use-case examples.

A common mistake is allowing sales staff to make performance statements based on overseas brochures or informal training sessions. If those statements are inaccurate or unsupported, both parties may end up dealing with the fallout.

Forgetting the end of the relationship

Many parties negotiate hard at the start and spend almost no time on exit rights. That can be expensive later. Unsold stock, replacement parts, warranty support, service commitments and customer ownership all become contentious if the agreement ends suddenly.

Before you spend money on setup, warehousing or training, make sure the contract says what happens on termination. This is particularly important if the distributor will invest heavily in market development, clinical training or local support staff.

FAQs

What is a medical device distribution agreement?

It is a contract between a supplier and a distributor that sets the terms for supplying, promoting and selling medical devices. In New Zealand, it should also allocate responsibility for compliance, complaints, recalls, product information and marketing conduct.

Can I use a standard overseas distribution template in New Zealand?

Sometimes as a starting point, but it should usually be adapted. Overseas templates often use foreign regulatory language, weak recall wording, or liability settings that do not reflect the actual New Zealand market arrangement.

Who should be responsible for recalls under the agreement?

The contract should split this clearly rather than leave it implied. It should state who investigates issues, who communicates with customers, who pays costs, and who decides whether stock must be withdrawn or replaced.

Do exclusive distribution rights need to be written down?

Yes. If exclusivity matters to the commercial deal, the agreement should spell out the territory, channels, reserved accounts, performance conditions and what happens if targets are missed.

What if the distributor makes unauthorised product claims?

The agreement should prohibit unapproved claims and require the distributor to use authorised materials only. It should also include indemnity, compliance and termination provisions so the supplier has a clear response if misleading statements are made.

Key Takeaways

• A medical device distribution agreement should deal with compliance, safety and liability issues, not just pricing and territory.
• Before you sign, check who is responsible for importation, product information, marketing approvals, complaints, recalls and customer communication.
• Exclusivity must be stated clearly, including channels, reserved accounts and any sales targets needed to keep those rights.
• Warranty, indemnity and liability clauses need special attention because product defects and recall costs can be far more expensive than standard fee-based liability caps assume.
• Exit planning matters, especially for unsold stock, warranty support, training commitments and handover of customer relationships.

If you want help with exclusivity terms, recall and complaint clauses, liability allocation, supplier and distributor obligations, or a contract review, you can reach us on 0800 002 184 or team@sprintlaw.co.nz for a free, no-obligations chat.